Souhaitez-vous accéder aux communiqués récents ?

Chicago, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The global immuno-oncology drugs market was valued at US$ 35.78 billion in 2025 and is expected to reach US$ 185.69 billion by 2035, growing at a CAGR of...

BETHESDA, Md., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of...

Monte Rosa Therapeutics Announces Positive Interim Phase 1 Data of MRT-8102 Demonstrating Profound CRP Reductions in Elevated CVD-risk Subjects

BBO-8520 monotherapy in patients with KRASG12C non-small cell lung cancer (NSCLC) showed a 65% objective response rate (ORR) and a 66% 6-month progression-free survival (PFS), with 83% of patients...

- Program will expand access in certain regions where Revuforj is not available commercially, as permitted by local regulations - - Program will be launched in parts of Eurasia, Central and Southeast...

Anchorage Alaska, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Nova Minerals Limited (“Nova” or the “Company”) (NASDAQ: NVA) (ASX: NVA) (FRA: QM3) ) is pleased to announce further broad, near-surface gold...

Beijing, China, Jan. 06, 2026 (GLOBE NEWSWIRE) -- At the “Shanghai Cooperation Organization Plus” Meeting in North China’s port city of Tianjin in September 2025, Chinese President Xi Jinping...

New York City, Jan. 06, 2026 (GLOBE NEWSWIRE) -- In 2026, in this evolving landscape, the demand for a free welcome bonus no deposit required real money has surged, yet players are increasingly...

BlackboxStocks (NASDAQ: BLBX) Merger Target, REalloys and Mission Critical Materials Form Strategic Partnership

Dublin, Jan. 06, 2026 (GLOBE NEWSWIRE) -- The "SYK Inhibitors Market, Drug Price, Sales & Clinical Trials Outlook 2030" report has been added to ResearchAndMarkets.com's offering.Report...